| ≤55 years | >55 years | ||
| Age (median) | 48 (30 - 55) | 69 (56 - 100) | <0.01 |
| Male (%) | 53% | 50% | 0.24 |
| BMI (kg/m2) | 27.4 (19.3 - 41.8) | 27.5 (14.8 - 65) | 0.14 |
| Diabetes Mellitus (%) | 25% | 44% | <0.01 |
| Hypertension (%) | 68% | 86% | <0.01 |
| Tabagism (%) | 67% | 34% | <0.01 |
| Familial history of CD (%) | 15% | 10% | 0.01 |
| Dyslipidemia (%) | 43% | 53% | 0.003 |
| Stable angina (%) | 13% | 15% | 0.69 |
| HF (%) | 3% | 9% | 0.002 |
| AMI (%) | 27% | 42% | <0.01 |
| Previous CABG (%) | 10% | 19% | <0.01 |
| Previous PCI (%) | 21% | 28% | 0.01 |
| Hb (g/dL) | 14.35 ± 1.91 | 13.57 ± 1.87 | <0.01 |
| Cr (mg/dL) | 1.35 ± 1.54 | 1.3 ± 1.11 | 0.57 |
| Troponin (pico) (ng/dL) | 13.70 ± 51.58 | 10.88 ± 23.62 | 0.26 |
| LVEF (%) | 42.73 ± 23.46 | 44.19 ± 21.49 | 0.42 |
| Aspirin (%) | 95% | 97% | 0.12 |
| B-blocker (%) | 71% | 73% | 0.72 |
| Enoxaparin (%) | 77% | 80% | 0.29 |
| Clopidogrel (%) | 59% | 53% | 0.1 |
| ACE inhibitor (%) | 60% | 60% | 0.98 |
| Statin (%) | 83% | 84% | 0.7 |